NEJM AI on Ovid
-
What is NEJM AI?
NEJM AI is a peer‑reviewed journal from NEJM Group focused on the application of artificial intelligence and machine learning in medicine, with an emphasis on rigorous evidence and real‑world clinical relevance.
-
What types of content does NEJM AI publish?
NEJM AI publishes original research, reviews, perspectives, case studies, datasets, protocols, benchmarks, and policy‑focused content addressing AI across clinical practice and healthcare operations.
-
How does NEJM AI differ from other AI or technology journals?
NEJM AI emphasizes clinical impact, methodological rigor, and practical relevance, helping readers evaluate not only what is possible with AI, but what is effective, safe, and appropriate in healthcare settings.
-
How does NEJM AI support clinical and organizational decision‑making?
By presenting trusted, expert‑reviewed evidence on the benefits and limitations of AI, NEJM AI helps institutions make informed, data‑driven decisions about adoption, governance, and policy.
-
How is NEJM AI delivered on the Ovid platform?
NEJM AI is delivered to institutions through the Ovid platform as a subscribed resource. When licensed, users can discover and search NEJM AI content within Ovid and may cross-search it alongside other NEJM Group resources to which the institution also subscribes, supporting integrated research workflows without implying automatic access to additional content.
-
How do users access NEJM AI content?
NEJM AI is accessed by institutions through the Ovid platform. Authorized users can discover and use NEJM AI content within Ovid, with access reflecting the institution’s licensed subscriptions and entitlements.
-
How does NEJM AI support research and education?
NEJM AI enhances research and education by providing high‑quality AI‑focused scholarship, multimedia content, and expert perspectives that support teaching, learning, and innovation.
-
What value does NEJM AI provide to medical libraries?
NEJM AI enables libraries to support emerging institutional priorities in AI, digital health, and innovation while maintaining the editorial rigor and credibility associated with NEJM Group.
-
What implementation and support services are available?
Ovid provides implementation, training, configuration, and ongoing global support to help institutions maximize the value of NEJM AI within their collections.
NEJM Catalyst Innovations in Care Delivery on Ovid
-
What is NEJM Catalyst Innovations in Care Delivery?
NEJM Catalyst Innovations in Care Delivery is a publication from NEJM Group focused on healthcare delivery transformation, featuring practical solutions, big ideas, and real‑world examples from healthcare leaders and experts. Its content is designed to support improvements in quality, operations, policy, and system‑level care delivery.
-
Who is NEJM Catalyst intended for?
NEJM Catalyst is designed for healthcare leaders, quality and safety teams, clinicians in leadership roles, educators, and administrators who are responsible for improving care delivery, organizational performance, and patient outcomes.
-
How does NEJM Catalyst differ from The New England Journal of Medicine?
While The New England Journal of Medicine focuses on clinical research and practice‑changing science, NEJM Catalyst concentrates on how care is delivered — including leadership, operations, policy, and system‑level innovation — complementing clinical literature with applied, organizational insights.
-
What types of content are included in NEJM Catalyst?
Content includes expert commentary, case examples, and research‑informed reports addressing urgent challenges in healthcare delivery. Articles are written to be accessible, practical, and grounded in clinical and operational context, supporting real‑world application.
-
How is NEJM Catalyst delivered on the Ovid platform?
Institutions can access NEJM Catalyst Innovations in Care Delivery through the Ovid platform, where it is integrated with other NEJM Group resources. This allows licensed users via the Ovid platform to search, browse, and link Catalyst content alongside related journals and evidence resources.
-
Do subscribers get access outside of Ovid?
Yes. Institutional subscribers to NEJM Catalyst via Ovid also have access to the content on Catalyst.nejm.org, providing flexibility for users who prefer either platform.
-
How does NEJM Catalyst support organizational decision‑making?
NEJM Catalyst supports decision‑making by providing actionable insights and industry‑relevant perspectives, including research reports informed by surveys of the NEJM Catalyst Insights Council, a large community of healthcare leaders.
-
How does NEJM Catalyst benefit medical libraries?
NEJM Catalyst helps libraries support quality teams, educators, and leadership audiences by expanding access beyond clinical research to include care delivery innovation, leadership insights, and system‑level improvement strategies.
-
What support is available for institutions implementing NEJM Catalyst on Ovid?
Ovid provides award-winning ongoing support, including configuration, training, promotion, and 24/7 assistance in multiple languages, to help institutions maximize the value of NEJM Group resources.
NEJM + NEJM Evidence on Ovid
-
What is the NEJM + NEJM Evidence package?
The NEJM + NEJM Evidence package provides institutional access to two authoritative journals from NEJM Group: The New England Journal of Medicine, which focuses on late‑stage, practice‑changing clinical research, and NEJM Evidence, which offers in‑depth analysis of early‑stage and follow‑up clinical trials. -
Why are NEJM and NEJM Evidence offered together?
Together, NEJM and NEJM Evidence support a more complete evidence continuum by pairing landmark clinical trials with deeper methodological insight and early‑phase research to inform clinical, research, and policy decisions. -
How does NEJM Evidence complement NEJM?
While NEJM emphasizes critical late‑stage trial findings, NEJM Evidence provides a different lens on early‑stage studies, trial design, and methodology, helping readers better evaluate emerging evidence and its implications for practice. -
Who is the NEJM + NEJM Evidence package intended for?
The package is designed for clinicians, researchers, educators, healthcare leaders, and policymakers who need trusted, evidence‑based insights to support patient care, research evaluation, education, and health policy development. -
What types of content are included in NEJM Evidence?
NEJM Evidence publishes original research, systematic reviews, and analyses that examine trial methodology, early‑phase studies, and follow‑up research to provide context and deeper understanding of clinical evidence. -
How does this package support evidence evaluation?
The combined access enables streamlined evidence evaluation by helping institutions stay current with rapid developments, assess study quality, and understand both clinical impact and methodological rigor. -
How does the package benefit clinical practice and education?
By offering comprehensive insights across the research lifecycle, the package supports clinical decision‑making, enriches education and training, and helps translate evidence into practice and policy. -
What value does the package provide to medical libraries?
The package allows libraries to deliver trusted, high‑impact clinical journals while supporting diverse institutional needs, including patient care, research evaluation, accreditation, and education. -
What support is available for institutions implementing the package on Ovid?
Ovid provides award‑winning ongoing support, including configuration, training, promotion, and 24/7 assistance in multiple languages to help institutions maximize the value of NEJM Group resources.